Finch Therapeutics Group, Inc.
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that i…
Biotechnology
US, Somerville [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Finch Therapeutics Group, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDFinch Therapeutics Group, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Finch Therapeutics Group, Inc..
If you want to see a demo, head over to the financial segments of AAPL